IKS IPO: GMP, Date and Price | IPO Opening Date: 12th Dec 2024
 |
The IKS IPO (Inventurus Knowledge Solutions IPO) is creating a lot of buzz in the Indian stock market. If you're looking to invest in this IPO, here’s an easy guide to understand all the important details.
Important Dates for the IKS IPO
IPO Opening Date: 12th December 2024
IPO Closing Date: 16th December 2024
Price Band: ₹1265 to ₹1329 per share
IPO GMP (Grey Market Premium): ₹275
Listing Date: 19th December 2024
Lot Size: 11 Shares (Minimum Investment: ₹14,619)
About IKS Health
Inventurus Knowledge Solutions (IKS Health) is a company that provides healthcare services like:
Medical documentation management
Virtual medical scribing
Administrative support
With more than 778 healthcare organizations as clients, including big names like Mass General Brigham Inc. and Texas Health Care PLLC, IKS Health has built a strong reputation. The company helps healthcare providers by reducing administrative work so they can focus more on patient care.
IKS Health IPO Financials
Here’s a look at the company’s financial performance for FY2024:
Revenue: ₹1,857.94 crore
Profit After Tax (PAT): ₹370.49 crore
Net Worth: ₹1,157.86 crore
Total Assets: ₹3,027.52 crore
These numbers show that the company is growing and earning well, which makes it an attractive investment option.
What is IPO GMP Today?
As of 9th December 2024, the IPO GMP (Grey Market Premium) for IKS Health is ₹275. This means that people in the grey market are willing to buy the IPO shares at a premium price of ₹275 above the issue price. This shows that there’s a strong demand for IKS Health shares before they are listed.
Based on this premium, the stock could list at around ₹1604 when it hits the market on 19th December 2024. This could bring some good gains to investors who buy the IPO at the issue price of ₹1265 to ₹1329.
Why Should You Consider Investing in the IKS IPO?
Proven Clientele: IKS Health has worked with big healthcare organizations, showing that they are trusted in the industry.
Scalable Business: The company provides cost-effective solutions, which gives it a good chance for long-term growth.
Strong Market Sentiment: With a solid IPO GMP, investors are showing strong interest in this IPO, making it a promising option.
Things to Consider
While the IKS IPO looks promising, there are a few things to keep in mind:
High Valuation: The IPO's price might seem a bit high compared to other companies in the same sector.
Regulatory Risks: Healthcare companies have to follow many rules and regulations, which can change and impact business.
Conclusion
The IKS IPO offers a great opportunity for investors looking to enter the healthcare technology space. With strong financials, a growing client base, and good market sentiment, this IPO has a lot of potential. But like any investment, it’s important to understand the risks and evaluate carefully before making a decision.
Disclaimer: This article is for informational purposes only. Please consult with a financial advisor before investing.
Comments
Post a Comment